- Home
- CMCL vs BCYC Comparison
CMCL vs BCYC Comparison
Compare CMCL & BCYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CMCL | BCYC |
|---|---|---|
| Founded | 1992 | 2009 |
| Country | Jersey | United Kingdom |
| Employees | N/A | N/A |
| Industry | Precious Metals | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 508.3M | 476.6M |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | CMCL | BCYC |
|---|---|---|
| Price | $29.21 | $6.63 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 11 |
| Target Price | ★ $28.00 | $18.73 |
| AVG Volume (30 Days) | 213.8K | ★ 241.6K |
| Earning Date | 11-10-2025 | 02-24-2026 |
| Dividend Yield | ★ 1.95% | N/A |
| EPS Growth | ★ 908.66 | N/A |
| EPS | ★ 2.58 | N/A |
| Revenue | ★ $228,245,000.00 | $28,339,000.00 |
| Revenue This Year | $55.55 | N/A |
| Revenue Next Year | $7.57 | N/A |
| P/E Ratio | $11.13 | ★ N/A |
| Revenue Growth | ★ 38.04 | N/A |
| 52 Week Low | $8.81 | $6.03 |
| 52 Week High | $38.75 | $15.47 |
Technical Indicators
Market Signals| Indicator | CMCL | BCYC |
|---|---|---|
| Relative Strength Index (RSI) | 61.25 | 44.14 |
| Support Level | $25.68 | $6.30 |
| Resistance Level | $27.41 | $7.00 |
| Average True Range (ATR) | 1.36 | 0.31 |
| MACD | 0.47 | -0.03 |
| Stochastic Oscillator | 98.29 | 33.85 |
Price Performance
Historical ComparisonAbout CMCL Caledonia Mining Corporation Plc
Caledonia Mining Corp PLC is a gold exploration, development, and mining company. The company's segment includes Blanket, South Africa, Bilboes Oxide mine, and E&E projects. The company generates the majority of its revenue from the Blanket project. The Blanket Mine is located in the south-west of Zimbabwe and operates at a depth of approximately 750 meters below the surface. The company's project includes Maligreen and Motapa.
About BCYC Bicycle Therapeutics plc
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.